Nutritional Status
2
Pipeline Programs
6
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
5 companies ranked by most advanced pipeline stage
Fresenius KabiGermany - Bad Homburg
2 programsNutrition Insights Day AsiaN/A1 trial
Screening Day Latin AmericaN/A1 trial
Active Trials
AbbottABBOTT PARK, IL
1 programNutritional Status of Cerebral Palsy Patients in TurkeyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
GSKGSK1325756
Fresenius KabiNutrition Insights Day Asia
AbbottNutritional Status of Cerebral Palsy Patients in Turkey
Fresenius KabiScreening Day Latin America
Clinical Trials (4)
Total enrollment: 2,907 patients across 4 trials
Pharmacokinetics and Safety of GSK1325756 in Elderly Subjects and Adult Subjects of in the Fed and Fasted States and in the Presence of a Proton Pump Inhibitors
Start: Apr 2010Est. completion: May 201032 patients
Phase 1Completed
Nutrition Insights Day Asia
Start: Mar 2019Est. completion: Jun 2019590 patients
N/ACompleted
Nutritional Status of Cerebral Palsy Patients in Turkey
Start: Nov 2015Est. completion: Apr 20161,123 patients
N/ACompleted
Screening Day Latin America
Start: Oct 2015Est. completion: Sep 20161,162 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
6 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.